evinacumab
Sign in to saveAlso known as Evkeeza
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH).
In the Vinony graph
Vinony's link graph records 498 inbound references to evinacumab, and connects out to human, liver and bone.
It sits within the topics Chemicals that do not have a ChemSpider ID assigned, Drugs that are a monoclonal antibody and Drugs with non-standard legal status.
Vinony links it to 9 Wikipedia language editions.
Wikidata facts
- Subclass of
- chemical compound
Show 1 more fact
- subject has role
- monoclonal antibody
via Wikidata · CC0
~3 min read
Encyclopedic overview
5 sectionsContents
- History
- Society and culture
- Legal status
- References
- Further reading
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH).
Common side effects include nasopharyngitis (cold), influenza-like illness, dizziness, rhinorrhea (runny nose), and nausea. Serious hypersensitivity (allergic) reactions have occurred in the Evkeeza clinical trials.
Excerpted from Wikipedia’s “evinacumab” article, available under the CC BY-SA 4.0 licence.